USFDA approves intramuscular administration for Merck’s MMRV Family of Vaccines: M-M-RII, VARIVAX, ProQuad Ruchika Sharma7 March 2023 11:22 AM ISTProQuad is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12...
Bristol Myers Squibb Reblozyl gets European Commission nod for anemia due to Beta Thalassemia Ruchika Sharma5 March 2023 11:30 AM ISTReblozyl, a first-in-class therapeutic option, promotes late-stage red blood cell maturation in animal models.
Merck scraps another prostate cancer study as Keytruda therapy disappoints Ruchika Sharma1 March 2023 2:15 PM ISTNew Delhi: Merck & Co said on Tuesday it will stop a late-stage trial evaluating a combination therapy with its cancer drug Keytruda after interim...
Pfizer in talks to acquire Seagen for likely for more than USD 30 bilion - WSJ Ruchika Sharma27 Feb 2023 3:30 PM ISTUS: Pfizer Inc is in early talks to acquire drugmaker Seagen Inc, the Wall Street Journal reported late on Sunday, citing people familiar with the...
EU drug regulator advices against market nod for Merck COVID pill Lagevrio for adults Ruchika Sharma26 Feb 2023 3:45 PM ISTUS: The European Union's drug regulator said on Friday its Committee for Medicinal Products for Human Use has advised against market authorisation of...
Moderna-Merck gets USFDA Breakthrough Therapy Designation for personalized mRNA cancer vaccine in combination with KEYTRUDA to treat high risk melanoma Ruchika Sharma23 Feb 2023 2:45 PM ISTCambridge: Moderna, Inc. and Merck have announced that mRNA-4157/V940, an investigational personalized mRNA cancer vaccine, in combination with...
LAGEVRI did not demonstrate statistically significant reduction in COVID risk following household exposure to another individual with COVID: Merck Ruchika Sharma23 Feb 2023 9:00 AM ISTRahway: Merck, known as MSD outside the United States and Canada, has announced that LAGEVRI (molnupiravir) did not demonstrate a statistically...
Merck announces positive results from phase 3 KEYNOTE-859 trial of Keytruda plus chemotherapy to treat patients with HER2-negative gastric or GEJ adenocarcinoma Ruchika Sharma20 Feb 2023 2:30 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
Merck gets USFDA priority review for PREVYMIS for Prophylaxis of Cytomegalovirus Disease in kidney transplant recipients at high risk Ruchika Sharma19 Feb 2023 4:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has accepted for...
MSD Pharma likely to participate in global tender for procurement of HPV vaccine against cervical cancer Ruchika Sharma16 Feb 2023 11:28 AM ISTThe Union Health Ministry is likely to float a global tender for HPV in April for 16.02 crore doses to be procured by 2026.
Drug companies face COVID cliff in 2023 as sales set to plummet Ruchika Sharma8 Feb 2023 3:27 PM ISTNew York: Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments are now up...
USFDA removes COVID test requirements for Merck, Pfizer pills Ruchika Sharma2 Feb 2023 12:15 PM ISTThe health regulator said individuals with recent known exposure with signs and symptoms may be diagnosed by their healthcare providers with COVID...
